Researchers identified three new all-oral drug regimens that include at least one of two new drugs for treatment of ...

Dr Shreya Dubey - Consultant - Neonatology & Paediatrics, CK Birla Hospital Gurgaon revealed that children are highly ...

According to the officials, the new regimen, called BPaL/BPaLM, includes medications bedaquiline, pretomanid, linezolid, and ...

Studies show under-representation of children and teens with multidrug-resistant TB, calling for focused case-finding efforts ...

Researchers analyzed global trends in multidrug-resistant tuberculosis (MDR-TB) among children and adolescents, revealing ...

Tuberculosis remains one of the top infectious disease killers worldwide, a challenge amplified by drug-resistant forms of the disease. Now, in a major step forward, an international clinical trial ...

Researchers reviewed previously published studies to understand trends in multidrug-resistant treatment of TB in children and ...

Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and ...

Aug. 12, 2020 — New drug regimen for multidrug-resistant tuberculosis shows early effectiveness in 85 percent of patients in a cohort including many with serious comorbidities. The results ...

Multidrug-resistance is a significant challenge in eliminating the bacterial disease, as the complication increases treatment ...

The rise in multidrug-resistant tuberculosis MDR-TB among children is raising global health concerns Learn about its causes alarming trends and the urgent need for action ...

Languages: English. Tuberculosis (TB), one of the leading infectious disease killers worldwide, has long posed a challenge, ...